Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic retinopathy

F L Ferris1

  • 1National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892.

Diabetes Care
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Diabetic retinopathy, a leading cause of vision loss, can be effectively treated with photocoagulation. Regular eye evaluations are crucial for people with diabetes to determine eligibility for this sight-saving intervention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical measurement of saturation discrimination.

Applied optics·2010
Same author

Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2007
Same author

Antioxidants and zinc to prevent progression of age-related macular degeneration.

JAMA·2002
Same author

Understanding the value of diabetic retinopathy screening.

Archives of ophthalmology (Chicago, Ill. : 1960)·2001
Same author

Evidence-guided ophthalmology.

Archives of ophthalmology (Chicago, Ill. : 1960)·2001
Same author

Journal editors should not require complete data sets for independent scrutiny.

Archives of ophthalmology (Chicago, Ill. : 1960)·2000
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Public Health

Background:

  • Diabetic retinopathy is a significant cause of vision impairment in the United States.
  • Vision loss from diabetes stems from proliferative retinopathy and macular edema.
  • Understanding the natural history and treatment is vital for patient care.

Purpose of the Study:

  • To review the natural history of diabetic retinopathy.
  • To identify indications for treatment of diabetic retinopathy.
  • To summarize effective therapeutic interventions.

Main Methods:

  • Review of natural history studies on diabetic retinopathy.
  • Analysis of major clinical trials sponsored by the National Eye Institute.
  • Synthesis of evidence on photocoagulation efficacy.

Related Experiment Videos

Main Results:

  • Diabetic retinopathy is a primary cause of vision disability.
  • Proliferative retinopathy and macular edema lead to vision loss.
  • Photocoagulation is a proven effective treatment for diabetic retinopathy complications.

Conclusions:

  • Regular screening for diabetic retinopathy is recommended for all diabetic patients.
  • Photocoagulation offers significant benefits for eligible individuals.
  • Referral guidelines include type I diabetes (>5 years duration) and all type II diabetes patients or those with retinopathy.